Patrick Emond

Patrick Emond

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2018 in Gut
Verified
Journal Article
Closed access
PDF file
THTim Hendrikx
Tim Hendrikx
YDYi Duan
Yi Duan
YWYanhan Wang
Yanhan Wang
JOJee-Hwan Oh
Jee-Hwan Oh
LALaura M Alexander
Laura M Alexander
BSBernd Schnabl
Bernd Schnabl
Objective: Antimicrobial C-type lectin regenerating islet-derived 3 gamma (REG3G) is suppressed in the small intestine during chronic ethanol feeding. Our aim was to determine the mechanism that underlies REG3G suppression during experimental alcoholic liver disease.Design: Interleukin 22 (IL-22) regulates expression of REG3G. Therefore, we investigated the role of IL-22 in mice subjected to chronic-binge ethanol feeding (NIAAA model).Results: In a mouse model of alcoholic liver disease, we found that type 3 innate lymphoid cells produce lower levels of IL-22. Reduced IL-22 production was the result of ethanol-induced dysbiosis and lower intestinal levels of indole-3-acetic acid (IAA), a microbiota-derived ligand of the aryl hydrocarbon receptor (AHR), which regulates expression of IL-22. Importantly, faecal levels of IAA were also found to be lower in patients with alcoholic hepatitis compared with healthy controls. Supplementation to restore intestinal levels of IAA protected mice from ethanol-induced steatohepatitis by inducing intestinal expression of IL-22 and REG3G, which prevented translocation of bacteria to liver. We engineeredLactobacillus reuterito produce IL-22 (L. reuteri/IL-22) and fed them to mice along with the ethanol diet; these mice had reduced liver damage, inflammation and bacterial translocation to the liver compared with mice fed an isogenic control strain and upregulated expression of REG3G in intestine. However,L. reuteri/IL-22 did not reduce ethanol-induced liver disease inReg3g–/–mice.Conclusion: Ethanol-associated dysbiosis reduces levels of IAA and activation of the AHR to decrease expression of IL-22 in the intestine, leading to reduced expression of REG3G; this results in bacterial translocation to the liver and steatohepatitis. Bacteria engineered to produce IL-22 induce expression of REG3G to reduce ethanol-induced steatohepatitis.

23 November 2015 in Journal of Proteome Research
Verified
Journal Article
Closed access
BDBinta Diémé
Binta Diémé
SMSylvie Mavel
Sylvie Mavel
Helene BlascoHelene Blasco
Helene Blasco
GTGabriele Tripi
Gabriele Tripi
FBFrédérique Bonnet-Brilhault
Frédérique Bonnet-Brilhault
PEPatrick Emond
Patrick Emond

1 October 2018 in Cell Metabolism
Verified
Journal Article
Closed access
MMMichela Miani
Michela Miani
JNJulie Le Naour
Julie Le Naour
EWEmmanuelle Waeckel-Enée
Emmanuelle Waeckel-Enée
SVSubash Chand Verma
Subash Chand Verma
MSMarjolène Straube
Marjolène Straube
Julien DianaJulien Diana
Julien Diana

10 April 2013 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
PEPatrick Emond
Patrick Emond
SMSylvie Mavel
Sylvie Mavel
NANacima Aïdoud
Nacima Aïdoud
LNLydie Nadal-Desbarats
Lydie Nadal-Desbarats
FMFrédéric Montigny
Frédéric Montigny
CAChristian R - Pr Christian Andres
Christian R - Pr Christian Andres


8 October 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Helene BlascoHelene Blasco
Helene Blasco
PCPhilippe Corcia
Philippe Corcia
CMCaroline Moreau
Caroline Moreau
SVSégolène Veau
Ségolène Veau
CFClémentine Fournier
Clémentine Fournier
CAChristian R - Pr Christian Andres
Christian R - Pr Christian Andres
Pathophysiological mechanisms involved in amyotrophic lateral sclerosis (ALS) are complex and none has identified reliable markers useful in routine patient evaluation. The aim of this study was to analyze the CSF of patients with ALS by 1H NMR (Nuclear Magnetic Resonance) spectroscopy in order to identify biomarkers in the early stages of the disease, and to evaluate the biochemical factors involved in ALS. CSF samples were collected from patients with ALS at the time of diagnosis and from patients without neurodegenerative diseases. One and two-dimensional 1H NMR analyses were performed and metabolites were quantified by the ERETIC method. We compared the concentrations of CSF metabolites between both groups. Finally, we performed principal component (PCA) and discriminant analyses. Fifty CSF samples from ALS patients and 44 from controls were analyzed. We quantified 17 metabolites including amino-acids, organic acids, and ketone bodies. Quantitative analysis revealed significantly lower acetate concentrations (p = 0.0002) in ALS patients compared to controls. Concentration of acetone trended higher (p = 0.015), and those of pyruvate (p = 0.002) and ascorbate (p = 0.003) were higher in the ALS group. PCA demonstrated that the pattern of analyzed metabolites discriminated between groups. Discriminant analysis using an algorithm of 17 metabolites revealed that patients were accurately classified 81.6% of the time. CSF screening by NMR spectroscopy could be a useful, simple and low cost tool to improve the early diagnosis of ALS. The results indicate a perturbation of glucose metabolism, and the need to further explore cerebral energetic metabolism.